Intra-trial Mean 25(OH)D and PTH Levels and Risk of Falling in Older Men and Women in the Boston STOP IT Trial.

Bess Dawson-HughesJifan WangKathryn BargerHeike A Bischoff-FerrariChristopher T Sempos Ramon A Durazo-ArvizuLisa Ceglia

Published in: The Journal of clinical endocrinology and metabolism (2022)

The findings highlight the importance of maintaining the circulating 25(OH)D level between 20 and 40 ng/mL, the range that is also recommended for bone health. At PTH levels within the normal range, there was no detectible independent association of PTH with fall risk.

Keyphrases

phase iii
study protocol
phase ii
clinical trial
healthcare
public health
community dwelling
mental health
bone mineral density
randomized controlled trial
open label
health information
body composition
bone loss
social media
placebo controlled